|
End-of-day quote
Dhaka S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 29.70 BDT | +2.77% |
|
+18.80% | +8.39% |
| Market Cap | 6.69B 54.34M 47.8M 45.2M 40.99M 76.99M 5.22B 77.43M 541M 209M 2.66B 204M 200M 8.55B | P/E 2024 |
50.8x | P/E 2025 | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.23B 262M 230M 218M 197M 371M 25.12B 373M 2.61B 1.01B 12.82B 983M 961M 41.2B | EV / Sales 2024 |
3.62x | EV / Sales 2025 | 7.99x |
| Free-Float |
74.17% | Yield 2024 |
1.45% | Yield 2025 | - |
| 1 day | +2.77% | ||
| 1 week | +18.80% | ||
| Current month | +13.79% | ||
| 1 month | +13.36% | ||
| 3 months | +3.12% | ||
| 6 months | -0.34% | ||
| Current year | +8.39% |
| 1 week | 25 |  | 33.2 |
| 1 month | 23.5 | | 33.2 |
| Current year | 23.5 | | 33.2 |
| 1 year | 22.9 | | 37.2 |
| 3 years | 22.9 | | 91.8 |
| 5 years | 22.9 | | 156.5 |
| 10 years | 22.9 | | 156.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zareen Karim
CEO | Chief Executive Officer | 48 | 2019-12-31 |
| Director of Finance/CFO | - | - | |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2014-09-09 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1984-12-31 |
Hasina Begum
BRD | Director/Board Member | 68 | 1996-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.77% | +18.80% | -17.96% | -62.69% | 56.43M | |
| +0.11% | +1.71% | +63.52% | +117.61% | 1,056B | |
| +0.27% | +0.92% | +51.33% | +73.35% | 655B | |
| +0.73% | +0.68% | +20.70% | +74.90% | 471B | |
| -1.36% | -2.58% | +40.20% | +42.33% | 342B | |
| +1.34% | +4.53% | +23.37% | +29.55% | 277B | |
| -0.48% | -0.54% | +13.56% | +13.50% | 257B | |
| +0.85% | +6.35% | +53.17% | +54.39% | 226B | |
| +0.85% | +1.10% | +35.78% | +101.82% | 189B | |
| -0.30% | -2.98% | -27.62% | -61.28% | 170B | |
| Average | +0.39% | +2.75% | +25.61% | +38.35% | 364.29B | |
| Weighted average by Cap. | -0.05% | +1.04% | +40.70% | +69.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.62B 86.24M 75.85M 71.73M 65.06M 122M 8.28B 123M 859M 332M 4.22B 324M 317M 13.57B | 4.08B 33.15M 29.15M 27.57M 25M 46.96M 3.18B 47.23M 330M 127M 1.62B 124M 122M 5.22B |
| Net income | 318M 2.58M 2.27M 2.15M 1.95M 3.66M 248M 3.68M 25.72M 9.93M 127M 9.7M 9.49M 407M | -415M -3.37M -2.97M -2.8M -2.54M -4.78M -324M -4.8M -33.58M -12.97M -165M -12.66M -12.39M -531M |
| Net Debt | 22.31B 181M 159M 151M 137M 257M 17.39B 258M 1.8B 697M 8.87B 680M 665M 28.51B | 25.54B 207M 182M 172M 156M 294M 19.91B 295M 2.07B 798M 10.16B 779M 762M 32.64B |
Employees
2,954
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | BDT 29.70 | +2.77% | 398,711 |
| 26-09-27 | BDT 28.90 | -4.30% | 4,383,703 |
| 26-09-24 | BDT 30.20 | +9.82% | 1,942,926 |
| 26-09-23 | BDT 27.50 | +10.00% | 366,088 |
| 26-09-22 | BDT 25.00 | 0.00% | 92,561 |
- Stock Market
- Stocks
- ORIONPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
